Full-Time

Senior Manager

Engineering-NPI

Posted on 9/3/2025

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Chattanooga, TN, USA

In Person

Category
Engineering Management (3)
, ,
Requirements
  • A Bachelor's degree or Master’s degree in an engineering or related technical discipline.
  • A history of at least 15 years of engineering and/or technical support roles including at least 5 years in technical management positions.
  • Accomplished track record in production environments where you owned the responsibilities for delivering results — particularly KPIs noted above.
  • Experience implementing and/or sustaining Manufacturing Excellence and Lean practices.
  • Demonstrated experiences with strategic and direct management of people in a fast paced and in complex manufacturing environments where products were made to stock and made to order.
  • Mastery of problem-solving skills and evidence that you are a critical thinker and thoughtful decision maker; certification as at least a Green Belt or equivalent (formal training in problem solving analysis, root cause analysis, and project management).
  • Demonstrated financial acumen with the capability to navigate a typical Profit and Loss Statement, able to explain how the delivered results can support the site’s financial performance targets.
  • A toolkit of leadership skills, including awareness of Emotional Intelligence and how you develop people.
  • A calm demeanor that transcends the high energy, changing production environment.
  • Well-developed skills for planning, executing, and delivering projects on time and on budget.
  • Willingness to consider relocation opportunities and rotational assignments (not required but may provide future career growth).
Responsibilities
  • Lead multiples teams of engineering managers or supervisors and senior level engineers in the support of multiple product lines or complex processes at a manufacturing site.
  • Lead these teams to develop and implement innovative solutions to resolve complex technical problems that impact ongoing or new operational or technological activities and initiatives.
  • Under your leadership, your team will be accountable for providing the technical support and leadership required to sustain and optimize ongoing production, ensure site quality, drive continuous improvement projects to completion, manage engineering and functional teams, and/or support the transfers of new products and new technologies into the site.
  • Be a Strategic Leader: Assume responsibility for all engineering support activities across multiple production areas at one of our manufacturing sites and accept accountability for delivering the Key Performance Goals/Targets established.
  • Serve as an integral member of the Site’s Leadership Team and contribute to the development of the Site’s Strategies and annual goals and objectives from which your Key Performance Goals/Targets are derived.
  • Lead your direct reports which include any combination of engineering managers or supervisors and individual performers.
  • Understand and adhere to Integer’s Values and all company policies, procedures, and work instructions defined in your training plan.
  • Ensure compliance to the established Quality Management System.
  • Ensure compliance to all Environmental, Health, Safety, and Security protocols.
  • Support the development of the site Hoshin Plan and lead the cross-functional execution of the manufacturing-related imperatives.
  • Develop and execute sustained Continuous Improvement processes.
  • Define the goals and objectives for your direct reports with supporting Key Performance Indicators (metrics in Safety, Quality, Delivery, and Productivity).
  • Promote talent by developing individual growth and development plans and organizational succession plans.
  • Manage by walking around -- going to the Gemba to observe and ask questions and being an active listener.
  • Model an open and inclusive communication style at the daily production boards, in the weekly engineering and operations’ project update meetings, and in the monthly KPI Board reviews and Town Hall meetings.
  • Engage with Associates at all levels and across all functions, finding time every week to join them for lunch, during breaks, and inviting them to your team meetings.
  • Ensure one/one time with your direct reports, regularly, to monitor performance and check in on progress to Individual Development Plans.
  • Interact directly with your customers, internal and external; participate actively in customer business reviews and during site visits and audits.
  • Partner with your peers on the Site Leadership Team, aligning on strategies, tactics, and actions needed to achieve the Site’s objectives.
  • Collaborate with the R&D and Product Development teams to appropriately support the Product Development Processes and Technology Development Processes with resources in support of new product and/or new technology launches.
  • Embed Quality within the Engineering team – “I own Quality.” Be a standard bearer for Quality in everything we do at Integer, by assuring adherence to our QMS, facilitating corrective and preventive actions, and contributing to the successful attainment of our quality KPI’s and journey to 5 Sigma.
  • Perform other duties, as needed and as directed.
  • Champion Manufacturing Excellence and Market Focused Innovation Strategy deployments: Be the site champion for deployment of the systems and tools to optimize all production activities across the site.
  • Embrace the Manufacturing Excellence culture based on the Integer Production System and its five focus areas: Strategy Alignment, Leadership of Sustained Change, Standardization, Associate Engagement, and Systems & Process Optimization.
  • Participate in the development of production plans with representatives from other departments to ensure production performance standards meet customer requirements.
  • Monitor the status of actual daily and longer-term performance against the production plan; ensure your team is driving actions to address off standard performance.
  • Review the Technology Roadmaps developed within a business or for a product line and assess what initiatives may be required at the site level to support implementation as well as likely impact on product growth strategies; develop strategic and tactical plans to provide supporting resources.
Desired Qualifications
  • Evidence that you learn, retain, and apply knowledge.
  • Willingness to relocate opportunities for future career growth (in addition to being listed as a requirement).
  • Staying up to date on new technologies, recent developments, and evolving learnings as they relate to your business or product line(s).
  • You remaining actively engaged in your chosen discipline and continuing professional development.
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Simplify Jobs

Simplify's Take

What believers are saying

  • Board initiated strategic review on April 30, 2026, exploring sale options.
  • Irenic Capital acquired $99M stake in Q4 2025 as top holding.
  • $200M share repurchase authorization signals management confidence in valuation.

What critics are saying

  • Class action lawsuits by Pomerantz and Bleichmar drain cash via settlements by Q4 2026.
  • Three new products cause 3-4% headwind, slashing H2 2026 margins.
  • Irenic activism forces sale at depressed valuation below $93 target in 12 months.

What makes Integer Holdings Corporation unique

  • Integer specializes in contract manufacturing for Cardio & Vascular medical devices.
  • Organic revenue grew 1.3% in Q1 2026 despite flat overall sales.
  • Robust pipeline targets above-market growth by 200 basis points in 2027.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Growth & Insights and Company News

Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Yahoo Finance
Mar 24th, 2026
Integer VP sells $70K in shares as stock drops 28% in a year

Integer Holdings Corporation shares fell 28% following an insider sale disclosure. Tom Thomas, the company's vice president and corporate controller, sold 825 shares of common stock in an open-market transaction on 13 March 2026, according to an SEC Form 4 filing. The transaction was valued at $70,000 at a reported price of $85 per share. The sale represented 15.85% of Thomas's direct holdings at the time. Following the transaction, Thomas holds 4,380 shares worth approximately $364,000. This marks Thomas's third open-market sale since 2018, following previous sales of 884 shares in November and 1,500 shares in April. Integer Holdings manufactures medical devices and components, generating $1.85 billion in trailing twelve-month revenue.

Yahoo Finance
Feb 26th, 2026
Integer Holdings Q4 earnings beat forecasts on strong Cardio & Vascular demand

Integer Holdings, a medical device manufacturer, reported fourth quarter revenue of $472.1 million and adjusted earnings per share of $1.76, both exceeding analyst expectations. The company posted 5% year-on-year revenue growth, driven by strong performance in its Cardio & Vascular segment. CEO Peyman Khales attributed $30 million in operational improvements to higher sales volume, manufacturing efficiencies and expense management. The company guided adjusted earnings per share of $6.54 for 2026, beating analyst estimates by 3.8%. During the earnings call, analysts questioned the narrowing of organic sales guidance, first quarter margin compression and the company's path to above-market growth in 2027. Management emphasised collaborative customer planning and reaffirmed its current strategy despite activist investor involvement.

Intellectia.AI
Feb 23rd, 2026
Irenic Capital takes $99M stake in Integer Holdings as medical device firm posts 8% sales growth

Irenic Capital Management has acquired a $99.11 million stake in Integer Holdings, purchasing 1,263,663 shares in Q4 2026. The position represents 13.7% of Irenic's assets under management, making it the fund's largest disclosed equity holding. Integer Holdings, a medical device company, achieved 8% sales growth in 2025, reaching $1.85 billion in revenue, with adjusted earnings per share rising 21% to $6.40. The company reported fourth-quarter sales of $472 million and net income of $62 million, up 22% year-over-year. Management projects 2026 adjusted earnings per share between $6.29 and $6.78, with plans to achieve organic growth exceeding market rates by 200 basis points in 2027. Benchmark analyst Robert Wasserman upgraded the stock from hold to buy with a $95 price target.

Yahoo Finance
Feb 23rd, 2026
Integer posts 21% adjusted EPS growth but warns of H1 2026 headwinds from slower product adoption

Integer Holdings reported strong 2025 results with sales up 8% and adjusted earnings per share rising 21% to $6.40, alongside margin expansion and $105 million in free cash flow. The company returned capital through a $50 million share repurchase and announced an additional $50 million accelerated share repurchase programme. However, management warned that three newer products representing approximately 6% of 2025 sales are experiencing slower-than-expected adoption, creating a 3%–4% headwind for 2026. The company expects flat-to-slightly-down sales and a 200–250 basis point hit to first-quarter operating margin, with recovery and margin expansion anticipated in the second half. Integer maintained its 2026 midpoint guidance, with year-end net debt expected at $1.17–1.19 billion and net leverage remaining at 3.0 times adjusted EBITDA.

Yahoo Finance
Feb 19th, 2026
Integer faces 2026 headwinds from delayed product launches despite $200M buyback and robust pipeline

Integer Holdings, a medical device contract manufacturing organisation, reported fourth-quarter sales of $472 million, up 5% year-over-year, with adjusted earnings per share at the high end of its October guidance range. For the full year 2025, sales increased 8% on a reported basis and over 6% organically, whilst adjusted operating income rose 13%. The company issued 2026 guidance expecting reported sales to be down 1% to up 1%, with a 3% to 4% headwind from three new products facing lower-than-expected market adoption. However, Integer's underlying business is expected to grow 4% to 6%, in line with the market. Integer repurchased $50 million of shares in Q4 and announced plans for an additional $50 million accelerated share repurchase programme under its $200 million authorisation.

INACTIVE